{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:00:28Z","timestamp":1790067628742,"version":"4.0.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005192","name":"California HIV\/AIDS Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>The increasingly unpredictable unregulated drug supply has intensified overdose morbidity and mortality and prompted growing interest in safer regulated supply as an upstream harm reduction strategy. Yet, safer supply programs cannot function effectively as stand-alone interventions. Their reach, acceptability, and equity will depend on surrounding infrastructure that supports people before enrollment, during transitions in substance use or dosing, and alongside ongoing use of unregulated substances. Harm reduction vending machines (HRVMs) are one low-barrier infrastructure model that can support safer supply ecosystems without conflating automated harm reduction supply distribution with regulated drug dispensing. Drawing on implementation experience from a Veteran-serving HRVM program across hospital, outpatient clinic, and permanent supportive housing settings, this article describes how HRVMs can expand access to drug checking supplies, naloxone, safer use materials, wound care and hygiene supplies, HIV and sexually transmitted infection prevention resources, and voluntary care linkage pathways while potentially reducing the need for face-to-face disclosure. Six HRVM infrastructure functions relevant to safer supply implementation are proposed: drug checking access, overdose prevention, safer use and wound care, health and wellness supplies, syndemic prevention, and noncoercive linkage to care. Design and evaluation considerations include privacy protection, product adaptability, co-design with people who use drugs, operational reliability, and the need to distinguish implementation metrics from clinical outcomes. Positioning HRVMs as safer supply-supporting infrastructure may help health systems, community programs, housing providers, and policymakers build more accessible, adaptive, and person-centered harm reduction ecosystems.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1955152","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:10:15Z","timestamp":1790064615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Harm reduction vending machines as safer supply-supporting infrastructure"],"prefix":"10.3389","volume":"17","author":[{"given":"Tessa","family":"Rife-Pennington","sequence":"first","affiliation":[{"name":"Pharmacy Service, San Francisco Veterans Affairs (VA) Health Care System","place":["San Francisco, CA, United States"]},{"name":"School of Pharmacy, University of California, San Francisco","place":["San\u00a0Francisco,\u00a0CA, United States"]},{"name":"Thomas J. Long School of Pharmacy, University of the Pacific","place":["San\u00a0Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112953","article-title":"Substances in fentanyl samples in the U.S. illicit drug supply: a decade of trends and regional variations using serial cross-sectional analysis","volume":"277","author":"Hasgul","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100898","article-title":"Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis","volume":"39","author":"Lim","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/add.70378","article-title":"Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States 2019-2024","volume":"121","author":"Zhu","year":"2026","journal-title":"Addiction"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103467","article-title":"Consuming illicit opioids during a drug overdose epidemic: illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market","volume":"99","author":"Duhart Clarke","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103643","article-title":"You can't go wrong being safe: motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs","volume":"103","author":"Reed","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01062-2","article-title":"Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative","volume":"21","author":"Walters","year":"2024","journal-title":"Harm Reduct J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/daaf125","article-title":"Navigating US illicit drug market volatility: harm reduction strategies employed by people who inject drugs","volume":"40","author":"Winiker","year":"2025","journal-title":"Health Promot Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(23)00058-x","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22210-8","article-title":"Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis","volume":"25","author":"Fischer","year":"2025","journal-title":"BMC Public Health"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi","year":"2022","journal-title":"Addiction"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B12","volume-title":"Safe Supply Concept Document","year":"2019"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/29767342261462675","article-title":"Upstream overdose prevention: why the US should pilot a safer, regulated drug supply","volume":"47","author":"Rife-Pennington","year":"2026","journal-title":"Subst Use Addctn J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00494-y","article-title":"Moving towards a continuum of safer supply options for people who use drugs: a qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada","volume":"17","author":"Foreman-Mackey","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2025.2497800","article-title":"Early experiences and impacts of a fentanyl powder safer supply program in Vancouver, Canada: a qualitative study","volume":"51","author":"Ivsins","year":"2025","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104157","article-title":"Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis","volume":"120","author":"Karamouzian","year":"2023","journal-title":"Int J Drug Policy"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104339","article-title":"Prescribed safer opioid supply: a scoping review of the evidence","volume":"125","author":"Ledlie","year":"2024","journal-title":"Int J Drug Policy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2025-301629","article-title":"Safer opioid supply clients' values and preferences: a systematic review and thematic synthesis of qualitative research","volume":"28","author":"Nafeh","year":"2025","journal-title":"BMJ Ment Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/29767342261421746","article-title":"In support of harm reduction supply distribution via vending machines: position statement of AMERSA, Inc","volume":"47","author":"Rife-Pennington","year":"2026","journal-title":"Subst Use Addctn J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00765-2","article-title":"A scoping review of implementation considerations for harm reduction vending machines","volume":"20","author":"Russell","year":"2023","journal-title":"Harm Reduct J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01236-6","article-title":"Vending machines for reducing harm associated with substance use and use disorders, and co-occurring conditions: a systematic review","volume":"22","author":"Zhang","year":"2025","journal-title":"Harm Reduct J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00817-7","article-title":"Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada","volume":"20","author":"Gagnon","year":"2023","journal-title":"Harm Reduct J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-020-00489-9","article-title":"It's helped me a lot, just like to stay alive: a qualitative analysis of outcomes of a novel hydromorphone tablet distribution program in Vancouver, Canada","volume":"98","author":"Ivsins","year":"2021","journal-title":"J Urban Health"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00875-x","article-title":"The utilization and delivery of safer smoking practices and services: a narrative synthesis of the literature","volume":"20","author":"Tapper","year":"2023","journal-title":"Harm Reduct J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0196-4","article-title":"Harm reduction principles for healthcare settings","volume":"14","author":"Hawk","year":"2017","journal-title":"Harm Reduct J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph14080928","article-title":"Personal hygiene practices among urban homeless persons in Boston, MA","volume":"14","author":"Leibler","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01376-9","article-title":"Barriers and facilitators to initiating and adhering to harm reduction services among people who inject drugs in the United States: a systematic review","volume":"23","author":"Nacht","year":"2026","journal-title":"Harm Reduct J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/29767342261426185","article-title":"Meeting veterans where they are: harm reduction supply distribution via vending machines","volume":"47","author":"Rife-Pennington","year":"2026","journal-title":"Subst Use Addctn J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2026.209991","article-title":"Smart harm reduction vending machines to improve public health: evaluating the utilization","volume":"187","author":"Zhang","year":"2026","journal-title":"J Subst Use Addict Treat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(23)00057-8","article-title":"Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review","volume":"11","author":"Degenhardt","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0390-3","article-title":"The syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions","volume":"15","author":"Perlman","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112732","article-title":"Sexually transmitted infection prevalence and testing coverage among people who inject drugs: a systematic review","volume":"273","author":"Price","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2196\/84317","article-title":"Use of vending machines to deliver oral rapid HIV self-tests to veterans: protocol for a pilot study","volume":"15","author":"Rife-Pennington","year":"2026","journal-title":"JMIR Res Protoc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.70038","article-title":"From an HCV and HIV point of view, it's been remarkable: a qualitative study about using prescribed safer supply to support people who use drugs along the HIV and HCV prevention and treatment cascades in Ontario, Canada","volume":"28","author":"Guta","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01222-y","article-title":"Discreet but accessible: a qualitative study with people who use drugs and service staff about the optimal design of a harm reduction vending machine in rural Kentucky","volume":"22","author":"Marschke","year":"2025","journal-title":"Harm Reduct J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2196\/93868","article-title":"Optimizing veteran-facing materials for vending machine-dispensed HIV self-testing: formative qualitative study","volume":"10","author":"Rife-Pennington","year":"2026","journal-title":"JMIR Form Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00747-4","article-title":"There's absolutely no downside to this, I mean, except community opposition: a qualitative study of the acceptability of vending machines for harm reduction","volume":"20","author":"Stewart","year":"2023","journal-title":"Harm Reduct J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/phh.0000000000002379","article-title":"From clinic to community: deploying harm reduction vending machines across a Veterans Affairs system","volume":"32","author":"Rife-Pennington","year":"2026","journal-title":"J Public Health Manag Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103474","article-title":"Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies","volume":"99","author":"Hayes","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2026.113168","article-title":"A geospatial analysis of access to syringe services programs in the United States 2023","volume":"284","author":"Humphrey","year":"2026","journal-title":"Drug Alcohol Depend"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-00947-6","article-title":"Feasibility of paying people who use drugs cash to distribute naloxone within their networks","volume":"21","author":"Lewis","year":"2024","journal-title":"Harm Reduct J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1955152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:10:16Z","timestamp":1790064616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1955152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":43,"alternative-id":["10.3389\/fpsyt.2026.1955152"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1955152","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1955152"}}